The PIK3 signalling pathway is essential for the maintenance of PCSCs, and Wang Lei et al. used the PI3K inhibitor BKM120 to study its combined effect with oHSV in prostate cancer [50]. The gene discussed is PIK3CG; the disease is prostate carcinoma.